A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

An at-home saliva test that assesses genetic risk of prostate cancer may be more accurate than PSA level or MRI.

A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them ...

Clarius Mobile Health, a pioneer in AI-powered handheld ultrasound, is introducing Clarius Prostate AI, an FDA cleared semi-automatic tool that quickly and accurately calculates prostate volume during ...

But he never seemed able to see the same doctor, and when a prostate specific antigen test came back in 2016 showing his ...

Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, has met a ...